سعر ميكستارد 30 اتش ام 100 وحدة دولية/مل 2024

Biphasic human insulin Mixtard 30 HM 100 IU/mL (30% soluble + 70% isophane), 5 × 3 mL Penfill cartridges, Novo Nordisk.

• Treatment of diabetes mellitus.Population: Patients with diabetes mellitusEuropean Medicines Agency (EMA)

• Most common side effect (more than 1 in 10): hypoglycaemia. Injection-site reactions, lipodystrophy and allergic reactions may occur.International label, same product · European Medicines Agency (EMA)

• Hypoglycaemia; hypersensitivity to human insulin or any excipient.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Never share needles, syringes, or pens between patients due to blood-borne pathogen risk.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypoglycaemia is the most common adverse effect; changes in insulin regimen, meal pattern, or physical activity can alter risk.International label, same product · European Medicines Agency (EMA), DailyMed (U.S. National Library of Medicine)
• Hypokalaemia may occur; monitor potassium when clinically indicated (e.g. with potassium-lowering drugs).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Oral antidiabetic agents, GLP-1 agonists, salicylates, sulfonamidesModerateMay increase insulin effect / hypoglycaemia risk; dose adjustment may be needed.DailyMed (U.S. National Library of Medicine)
• Corticosteroids, danazol, diuretics, sympathomimetics, thyroid hormonesModerateMay reduce insulin effect; monitor glucose and adjust dose.DailyMed (U.S. National Library of Medicine)
• Beta-blockersModerateMay mask symptoms of hypoglycaemia and prolong recovery from hypoglycaemia.DailyMed (U.S. National Library of Medicine)

• Insulin requirements usually fall in the first trimester and rise thereafter; careful monitoring is required. Human insulin is the preferred treatment during pregnancy when insulin is needed (ingredient-level / equivalent premix labelling).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Exogenous insulin is not expected to pose risk to the breastfed infant; maternal insulin needs may change during lactation.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Insulin human (soluble, neutral): Regulates glucose metabolism; promotes peripheral glucose uptake and inhibits hepatic glucose production.
• Insulin isophane human (NPH): Regulates glucose metabolism; promotes peripheral glucose uptake and inhibits hepatic glucose production.